NCT03356860 Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT03354611 Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging Status TERMINATED Phase PHASE2/PHASE3
NCT03351348 Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control Status RECRUITING Phase PHASE3
NCT03350854 Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients Status COMPLETED Phase NA
NCT03349177 Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE2/PHASE3
NCT03348293 Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction Status COMPLETED Phase PHASE1
NCT03346161 Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach Status COMPLETED Phase PHASE1
NCT03344536 A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03343691 Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay Status UNKNOWN Phase N/A
NCT03343145 A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT03340402 Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning Status WITHDRAWN Phase NA
NCT03337724 A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer Status COMPLETED Phase PHASE3
NCT03336827 Improving Emotion Regulation at the End of Breast Cancer Treatment Status COMPLETED Phase NA
NCT03333993 Mat Pilates in Women With Breast Cancer During Adjuvant Radiotherapy Status COMPLETED Phase NA
NCT03332797 A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03329950 A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1